Industry News
Osprey Medical completes $20m ASX IPO
US-based medical device company Osprey Medical (ASX:OSP) has completed its $20m IPO on the ASX. [ + ]
Australian biotechs bullish despite economy and policy concerns
The AusBiotech Biotechnology Industry Position Survey has found Australian biotechs are optimistic about growth despite concerns over the economic and political environment. [ + ]
ASTM program provides compliance evidence
A program sponsored and administered by ASTM International - the Supplier’s Declaration of Conformity - will be a major benefit to suppliers, by verifying to their customers their conformance with ASTM test methods. [ + ]
Scientists discover new fat over lunch
Uncovering new fats, or lipids, with links to diseases in the human eye (lens) is as easy as taking a lunch break, according to chemists from the ARC Centre of Excellence for Free Radical Chemistry and Biotechnology at the University of Wollongong. [ + ]
Application for registration under the R&D Tax Incentive
AusIndustry has launched a new publication outlining what will be required when businesses commence registering for the R&D Tax Incentive from 1 July 2012. [ + ]
Pharmaxis asthma treatment found safe, but is it effective?
A phase IIa trial of Pharmaxis’ (ASX:PXS) experimental allergic asthma drug, ASM8, has been shown safe, but more trials will be required to demonstrate efficacy. [ + ]
Edmund Optics 2012 Higher Education Grant Program accepting applications
Optical components provider Edmund Optics is now accepting applications for their 2012 Edmund Optics Higher Education Grant Program. [ + ]
Profiling proteins to treat prostate disorders
Innovative new technology has been used to identify and profile a novel combination of proteins that may improve treatment for prostate disorders. [ + ]
Sigma-Aldrich acquires Research Organics
Sigma-Aldrich has acquired all outstanding shares of Cleveland-based company Research Organics to expand its buffer production capacity and to increase its portfolio of PharmaGrade raw materials for the biopharmaceutical and diagnostic markets. [ + ]
One smart snip: uncovering the genetics of intelligence
There’s no gene for genius, but scientists have found that a tiny change in a single gene has an impact on brain size and general intelligence. [ + ]
New online award set to make science sexy
Science is set to become one of the hottest subjects on the timetable for students in Years Nine and 10, following the launch of the inaugural Science for Growth Awards. The awards are being piloted in New South Wales and Queensland before a national launch in 2013. [ + ]
Gene therapy hopes for X-linked lymphoproliferative disease
Researchers have uncovered why some individuals with X-linked lymphoproliferative live far longer than expected, which could lead to a gene therapy for the disease. [ + ]
Gene therapy hopes for X-linked lymphoproliferative
Researchers have uncovered why some individuals with X-linked lymphoproliferative live far longer than expected, which could lead to a gene therapy for the disease. [ + ]
vivoPharm buys RMIT's toxicology business
RMIT will sell its toxicology testing unit, RDDT, to vivoPharm Technologies in exchange for a 20% stake in the contract research organisation (CRO). [ + ]
Genes identified for common childhood obesity
An international collaborative study including researchers from The University of Western Australia (UWA) has identified at least two new gene variants that increase the risk of common childhood obesity. [ + ]
